Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$302,790,144
-$8,269,777 QoQ
Shares Held
1,192,228
-6.3% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
#153
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swiss Life Asset Management Ltd holds $1,469,110,886 across 10 Drug Manufacturers - General names. JNJ ranks #2 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
357,284 | $428,537,182 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,192,228 | $302,790,144 | |
| 3 | ABBV |
AbbVie Inc.
|
680,811 | $171,319,279 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,305,364 | $167,739,274 | |
| 5 | PFE |
Pfizer Inc
|
6,943,719 | $167,204,752 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,414,008 | $81,475,140 | |
| 7 | AMGN |
Amgen Inc
|
209,837 | $75,986,174 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
525,655 | $66,411,252 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $302,790,144 | 1,192,228 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $311,059,921 | 1,272,541 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $233,750,231 | 1,129,501 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $235,188,395 | 1,268,409 | Shares | Defined | 2025-12-02 | |
| 2025-06-30 | $197,726,320 | 1,294,444 | Shares | Sole | 2025-12-02 | |
| 2025-03-31 | $174,620,232 | 1,052,944 | Shares | Sole | 2025-12-02 | |
| 2024-12-31 | $139,975,961 | 967,888 | Shares | Sole | 2025-12-09 | |
| 2024-09-30 | $81,210,048 | 501,111 | Shares | Sole | 2025-12-09 | |
| 2024-06-30 | $74,984,318 | 513,029 | Shares | Defined | 2025-12-09 | |
| 2024-03-31 | $67,029,532 | 423,728 | Shares | Defined | 2025-12-09 | |
| 2023-12-31 | $76,169,996 | 485,964 | Shares | Sole | 2025-12-09 | |
| 2023-09-30 | $60,955,721 | 391,369 | Shares | Sole | 2025-12-09 | |
| 2023-06-30 | $59,610,371 | 360,140 | Shares | Defined | 2025-12-09 | |
| 2023-03-31 | $61,360,160 | 395,872 | Shares | Sole | 2025-12-09 | |
| 2022-12-31 | $60,618,860 | 343,158 | Shares | Sole | 2025-12-09 | |
| 2022-09-30 | $58,248,294 | 356,564 | Shares | Defined | 2025-12-09 | |
| 2022-06-30 | $64,320,925 | 362,351 | Shares | Sole | 2025-12-09 | |
| 2022-03-31 | $69,088,861 | 389,826 | Shares | Sole | 2025-12-09 | |
| 2021-12-31 | $71,029,460 | 415,207 | Shares | Sole | 2025-12-29 | |
| 2021-09-30 | $70,999,598 | 439,626 | Shares | Defined | 2025-12-29 | |
| 2021-06-30 | $73,450,976 | 445,860 | Shares | Defined | 2025-12-29 | |
| 2021-03-31 | $73,174,536 | 445,236 | Shares | Defined | 2025-12-29 | |
| 2020-12-31 | $70,591,854 | 448,544 | Shares | Sole | 2025-12-29 | |
| 2020-09-30 | $81,059,799 | 544,464 | Shares | Sole | 2025-12-29 | |
| 2020-06-30 | $80,454,563 | 572,101 | Shares | Defined | 2025-12-29 | |
| 2020-03-31 | $74,612,051 | 568,993 | Shares | Sole | 2025-12-29 | |
| No filing history on record for this holder in this stock. | ||||||